MED vs USNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

MED

39.2
AI Score
VS
USNA Wins

USNA

53.9
AI Score

Investment Advisor Scores

MED

39score
Recommendation
AVOID NEW MONEY

USNA

54score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MED USNA Winner
Forward P/E 12.4844 7.6982 USNA
PEG Ratio 0.972 0.6417 USNA
Revenue Growth -19.4% -3.6% USNA
Earnings Growth -87.2% -16.6% USNA
Tradestie Score 39.2/100 53.9/100 USNA
Profit Margin -13.6% -2.3% USNA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY USNA

Relative Price Performance (Last 90 Days)

MED 1M: +8.5% · 3M: +12.4% USNA 1M: -16.6% · 3M: -4.8%

Current Technical Phase

MED

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 57

RSI (14): 56.9 · Price: $12.86

USNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.1 · Price: $12.73

Fundamentals Snapshot

Metric MED USNA
Market Cap — —
Forward P/E -321.5 10.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.7% 0.8%
Operating Margin -0.1% 0.0%
EPS -3.70 -1.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, USNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.